Staff Profile | Faculty of Medical Sciences

Professor Azfar Zaman

Hon Clin Prof of Cardiology

Email: azfar.zaman@ncl.ac.uk

Publications

O'Brien G, Cruz-Garcia L, Majewski M, Grepl J, Abend M, Port M, Tichy A, Sirak I, Malkova A, Donovan E, Gothard L, Boyle S, Somaiah N, Ainsbury E, Ponge L, Slosarek K, Miszczyk L, Widlak P, Green E, Patel N, Kudari M, Gleeson F, Vinnikov V, Starenkiy V, Artiukh S, Vasyliev L, Zaman A, Badie C. FDXR is a biomarker of radiation exposure in vivo. Scientific Reports 2018, 8, 684.
Baumbach A, Zaman A, West NEJ, O'Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, De Belder A, Bouras G, Lansky A, Hill J, Mathur A, De Belder MA, Banning AP. Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry. EuroIntervention 2018, 13(13), 1554-1560.
Zaman AG. Orbita – Much ado about nothing?. Journal of the Royal College of Physicians of Edinburgh 2018, 48(1), 40-43.
Jackson M, Austin D, Kwok CS, Rashid M, Kontopantelis E, Ludman P, de Belder M, Mamas MA, Zaman A. The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society. Catheterization and Cardiovascular Interventions 2018, 92(6), E393-E402.
Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. Thyroid Hormones and Cardiovascular Function and Diseases. Journal of the American College of Cardiology 2018, 71(16), 1781-1796.
Iqbal J, Kwok CS, Kontopantelis E, De Belder MA, Ludman PF, Large A, Butler R, Gamal A, Kinnaird T, Zaman A, Mamas MA. Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts. Circulation: Cardiovascular Interventions 2017, 10(4), e004457.
Noman A, Balasubramaniam K, Alhous MHA, Lee K, Jesudason P, Rashid M, Mamas MA, Zaman AG. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus. Catheterization and Cardiovascular Interventions 2017, 89(7), 1195-1204.
Godschalk TC, Byrne RA, Adriaenssens T, Malik N, Feldman LJ, Guagliumi G, Alfonso F, Neumann F-J, Trenk D, Joner M, Schulz C, Steg PG, Goodall AH, Wojdyla R, Dudek D, Wykrzykowska JJ, Hlinomaz O, Zaman AG, Curzen N, Dens J, Sinnaeve P, Desmet W, Gershlick AH, Kastrati A, Massberg S, ten Berg JM. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry. JACC: Cardiovascular Interventions 2017, 10(24), 2548-2556.
Holroyd EW, Sirker A, Kwok CS, Kontopantelis E, Ludman PF, De Belder MA, Butler R, Cotton J, Zaman A, Mamas MA. The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry. JACC: Cardiovascular Interventions 2017, 10(13), 1283-1292.
Jabbar A, Pingitore A, Pearce SHS, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nature Reviews Cardiology 2017, 14, 39-55.
Fajadet J, Neumann F-J, Hildick-Smith D, Petronio S, Zaman A, Spence M, Wohrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S. Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): The PLATINUM PLUS all-comers randomised trial. EuroIntervention 2017, 12(13), 1595-1604.
Watt J, Egred M, Khurana A, Bagnall AJ, Zaman AG. 1-Year Follow-Up Optical Frequency Domain Imaging of Multiple Bioresorbable Vascular Scaffolds for the Treatment of Spontaneous Coronary Artery Dissection. JACC: Cardiovascular Interventions 2016, 9(4), 389-391.
Mamas MA, Nolan J, de Belder MA, Zaman A, Kinnaird T, Curzen N, Kwok CS, Buchan I, Ludman P, Kontopantelis E, British Cardiovasc Intervention So, Natl Inst Clinical Outcomes Res. Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database. Circulation 2016, 133(17), 1655-1667.
Myint PK, Kwok CS, Roffe C, Kontopantelis E, Zaman A, Berry C, Ludman PF, de Belder MA, Mamas MA, British Cardiovascular Intervention Society, Natl Inst Cardiovascular Outcomes Research. Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication. Stroke 2016, 47(6), 1500-U276.
Curzen NP, Nolan J, Zaman AG, Nørgaard BL, Rajani R. Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFR_CT RIPCORD Study. JACC: Cardiovascular Imaging 2016, 9(10), 1188-1194.
Jabbar A, Mohammed A, Khurana A, Das R, Zaman A, Edwards R. Local versus general anaesthesia in transcatheter aortic valve replacement – a tertiary centre experience. In: BCIS Advanced Cardiovascular Intervention (ACI) 2016 abstracts. 2016, London: BMJ Publishing Group.
Jabbar A, Khurana A, Mohammed A, Das R, Zaman A, Edwards R. Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement. American Journal of Cardiology 2016, 118(11), 1712-1716.
Kwok CS, Tiong D, Pradhan A, Andreou AY, Nolan J, Bertrand OF, Curzen N, Urban P, Myint PK, Zaman AG, Loke YK, Mamas MA. Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention. American Journal of Cardiology 2016, 118(4), 610-620.
Iqbal J, Kwok CS, Kontopantelis E, de Belder MA, Ludman PF, Giannoudi M, Gunning M, Zaman A, Mamas MA, British Cardiovascular Interventio, Natl Inst Cardiovascular Outcomes. Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery. Circulation: Cardiovascular Interventions 2016, 9(4), e003151.
Zeymer U, Widimsky P, Danchin N, Lettino M, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CF, Zaman A, Andell P, Li J, Jukema JW. P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. European Heart Journal Cardiovascular Pharmacotherapy 2016, 2(4), 229-243.
Mäkikallio T, Holm NR, Lindsay M, Spence M, Erglis A, Menown IBA, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RBA, Pentikainen M, Hervold M, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham ANJ, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016, 388(10061), 2743-2752.
Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians. Heart 2016, 102(20), 1648-1654.
Jabbar A, Mohammed A, Khurana A, Das R, Zaman A, Edwards R. Transcatheter aortic valve replacement: a comparison of the direct flow medical and sapien 3 aortic valves. In: BCIS Advanced Cardiovascular Intervention (ACI). 2016, London, UK: BMJ Publishing Group.
Danchin N, Lettino M, Zeymer U, Widimsky P, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, LopezSendón J, Tousek P, Weidinger F, Weston CF, Zaman A, Andell P, Li J, Jukema JW. Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. European Heart Journal - Cardiovascular Pharmacotherapy 2016, 2(3), 152-167.
Jukema JW, Lettino M, Widimsky P, Danchin N, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, DeLuca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Lopez-Sendón J, Tousek P, Weidinger F, Weston CF, Zaman A, Zeymer U. Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations. European Heart Journal Cardiovascular Pharmacotherapy 2015, 1, 232-244.
Kwok CS, Kontopantelis E, Kunadian V, Anderson S, Ratib K, Sperrin M, Zaman A, Ludman PF, De Belder MA, Nolan J, Mamas MA, Natl Inst Cardiovasc Outcomes Res, British Cardiovasc Intervention So. Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS). American Heart Journal 2015, 170(1), 164-172.e5.
Geisler T, Booth J, Tavlaki E, Karathanos A, Müller K, Droppa M, Gawaz M, Yanez-Lopez M, Davidson SJ, Stables RH, Banya W, Zaman A, Flather M, Dalby M. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel. PLoS One 2015, 10(8), e0135037.
Anderson SG, Ratib K, Myint PK, Keavney B, Kwok CS, Zaman A, Ludman PF, de Belder MA, Nolan J, Mamas MA, Natl Inst Cardiovasc Outcomes Res, British Cardiovasc Intervention S. Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society. Catheterization Cardiovascular Interventions 2015, 86(6), 965-972.
Kwok CS, Anderson SG, McAllister KSL, Sperrin M, O'Kane PD, Keavney B, Nolan J, Myint PK, Zaman A, Buchan I, Ludman PF, de Belder MA, Mamas MA, British Cardiovasc Intervention, Natl Inst Cardiovasc Outcomes Res. Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society. Catheterization and Cardiovascular Intervention 2015, 85(6), 944-951.
Kunadian V, Veerasamy M, Sinclair H, Qiu WL, Das R, Ahmed J, Purcell I, Edwards R, Zaman A, Bagnall A. Major Adverse Cardiovascular Events at 30-days were not Significantly different between Frail and non-frail older ( ≥75 Years) Patients with non ST Elevation Acute Coronary Syndrome Managed by Invasive Strategy: An Analysis from the ICON1 Study. In: BCS Annual Conference: Hearts and Genes. 2015, Manchester, UK: BMJ Publishing Group.
Spyridopoulos I, Noman A, Ahmed JM, Das R, Edwards R, Purcell I, Bagnall A, Zaman A, Egred M. Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention. European Heart Journal: Acute Cardiovascular Care 2015, 4(3), 270-277.
Kwok CS, Kontopantelis E, Myint PK, Zaman A, Berry C, Keavney B, Nolan J, Ludman PF, de Belder MA, Buchan I, Mamas MA, British Cardiovasc Intervention So, Natl Inst Cardiovasc Outcomes Res. Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12. European Heart Journal 2015, 36(25), 1618-1628.
Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, Bennaceur K, Zaman A, Keavney B, Spyridopoulos I. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. Journal of Clinical Investigation 2015, 125(8), 3063-3076.
Jabbar A, Ingoe L, Pearce S, Zaman A, Razvi S. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial. Trials 2015, 16, 115.
Koshy A, Balasubramaniam K, Noman A, Zaman AG. Antiplatelet Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Retrospective Observational Study of Prasugrel and Clopidogrel. Cardiovascular Therapeutics 2014, 32(1), 1-6.
Balasubramaniam K, Viswanathan G, Dragone J, Grose-Hodge R, Martin P, Troy S, Preston P, Zaman AG. Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study. Thrombosis and Haemostasis 2014, 112(1), 205-215.
Viswanathan G, Balasubramaniam K, Hardy R, Marshall S, Zaman A, Razvi S. Blood Thrombogenicity is Independently Associated with Serum TSH Levels in Post-Non-ST Elevation Acute Coronary Syndrome. Journal of Clinical Endocrinology and Metabolism 2014, 99(6), E1050-E1054.
Viswanathan GN, Marshall SM, Balasubramaniam K, Badimon JJ, Zaman AG. Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome. Thrombosis Research 2014, 133(5), 880-885.
Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning A, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S. Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? The RIPCORD Study. Circulation: Cardiovascular Interventions 2014, 7(2), 248-255.
Mamas MA, Anderson SG, O'Kane PD, Keavney B, Nolan J, Oldroyd KG, Perera D, Redwood S, Zaman A, Ludman PF, de Belder MA, British Cardiovasc Intervention, Natl Inst Cardiovasc Outcomes Res. Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society. European Heart Journal 2014, 35(43), 3004-3012.
Noman A, Alhous H, Veerasamy M, Bagnall A, Purcell I, Stewart A, Hannah A, Zaman A, Edwards R. Multi-vessel coronary artery disease is associated with early, but not late, mortality following primary percutaneous coronary intervention. In: ESC Congress 2014. 2014, Barcelona, Spain: Oxford University Press.
Kunadian V, Bawamia B, Maznyczka A, Zaman A, Qiu W. Outcomes Following Primary Percutaneous Coronary Intervention in the Setting of Cardiac Arrest: A Registry Database Study. European Heart Journal: Acute Cardiovascular Care 2014, 1-10.
Bundhoo S, Nallur-Shivu G, Ossei-Gerning N, Zaman A, Kinnaird TD, Anderson RA. Switching from transfemoral to transradial access for PCI: A single-center learning curve over 5 years. Journal of Invasive Cardiology 2014, 26(10), 535-541.
Viswanathan GN, Balasubramaniam K, Badimon JJ, Zaman AG, Marshall SM. Thrombogenicity in obese patients with Type 2 diabetes following non ST-elevation acute coronary syndrome: is inflammation the missing link?. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
Balasubramaniam K, Noman A, Das R, Kunadian V, Ivanauskiene T, Zaman A. Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. In: British Cardiovascular Society Annual Conference. 2013, London, UK: BMJ Group.
Noman A, Balasubramaniam K, Das R, Ang D, Kunadian V, Ivanauskiene T, Zaman AG. Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: An Observational Study. Cardiovascular Therapeutics 2013, 31(6), 363-369.
Collins K, Balasubramaniam K, Viswanathan G, Natasari A, Tarn J, Lendrem D, Mitchell S, Zaman A, Ng W-F. Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome. BMJ Open 2013, 3(5), e002739.
Viswanathan GN, White KE, Zaman AG, Marshall SM. Clopidogrel alters thrombus quantity and quality in Type 2 diabetes. In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell Publishing Ltd.
Kunadian V, Harper A, Bawamia B, Zaman A. Drug eluting stents versus bare metal stents in primary PCI. Future Medicine 2013. In Press.
Kunadian V, Qiu WL, Bawamia B, Veerasamy M, Jamieson S, Zaman A. Gender Comparisons in Cardiogenic Shock During ST Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. American Journal of Cardiology 2013, 112(5), 636-641.
Balasubramaniam K, Viswanathan GV, Marshall SM, Badimon JJ, Razvi S, Zaman AG. Higher Thrombus Burden in Patients with Subclinical Hypothyroidism after Non ST Elevation Acute Coronary Syndrome. In: British Cardiovascular Society Annual Conference. 2013, London, UK: BMJ Publishing Group.
Badar A, Scaife J, Yan AT, Robinson SD, Zaman AG, Purcell IF, Ahmed JM, Egred M, Edwards RJ, Spyridopoulos I, Keavney BD, Bagnall AJ. Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome. Journal of Invasive Cardiology 2013, 25(8), 397-401.
Badar A, Scaife J, Yan AT, Robinson SD, Zaman AG, Purcell IF, Ahmed JM, Egred M, Edwards RJ, Spyridopoulos I, Keavney BD, Bagnall AJ. Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome. Journal of Invasive Cardiology 2013, 25(8), 397-401.
Viswanathan GN, Balasubramaniam K, Harper AG, Bawamia B, Marshall SM, Badimon JJ, Zaman AG. Higher thrombus, altered clot kinetics and fibrin architecture in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome. In: Congress of the European Society of Cardiology (ESC). 2012, Munchen, Germany: Oxford University Press.
Balasubramanian K, Viswanathan GN, Marshall SM, Zaman AG. Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy. Cardiology Research and Practice 2012, 909154.
Kunadian V, Veerasamy M, Jamieson S, Zaman A. Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study. In: British Cardiovascular Society Annual Conference. 2012, Manchester, UK: BMJ Group.
Kunadian V, Veerasamy M, Jamieson S, Zaman A. Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study. In: European Association of Percutaneous Cardiovascular Interventions (EUROPCR). 2012, Paris, France.
Kunadian V, Veerasamy M, Zaman A. Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study. In: Congress of the European Society of Cardiology (ESC). 2012, Munchen, Germany: Oxford University Press.
Kunadian V, Pugh A, Zaman AG, Qiu WL. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coronary Artery Disease 2012, 23(7), 469-479.
Bundhoo SS, Earp E, Ivanauskiene T, Kunadian V, Freeman P, Edwards R, Kinnaird TD, Zaman A, Anderson RA. Saphenous vein graft percutaneous coronary intervention via radial artery access: Safe and effective with reduced hospital length of stay. American Heart Journal 2012, 164(4), 468-472.
Viswanathan GN, Marshall SM, Schechter CB, Balasubramaniam K, Badimon JJ, Zaman AG. Thrombus and antiplatelet therapy in type 2 diabetes mellitus: A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina. Thrombosis and Haemostasis 2012, 108(5), 937-945.
Kidambi A, Mayurathan G, Viswanathan G, Schechter C, Zaman AG. Unfractionated Heparin during Elective PCI: Fixed Dose or Weight Adjusted?. Cardiovascular Therapeutics 2012, 30(1), 1-4.
Cubbon RM, Gale CP, Kearney LC, Schechter CB, Brooksby WP, Nolan J, Fox KAA, Rajwani A, Baig W, Groves D, Barlow P, Fisher AC, Batin PD, Kahn MB, Zaman AG, Shah AM, Byrne JA, Lindsay SJ, Sapsford RJ, Wheatcroft SB, Witte KK, Kearney MT. Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras. Circulation. Heart Failure 2011, 4(4), 396-403.
Joshi NV, Bawamia BR, Jamieson S, Zaman A, Edwards R. Evaluating a nurse led triage process in treating patients with left bundle branch block (LBBB) referred for primary percutaneous coronary intervention (pPCI). In: British Cardiovascular Society Annual Conference. 2011, Manchester, UK: BMJ Group.
Joshi N, Bawamia BR, Jamieson S, Zaman A, Edwards R. Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI). In: American Thoracic Society 2011 International Conference. 2011, Denver, Colarado: American Thoracic Society.
Joshi N, Bawamia BR, Jamieson S, Zaman A, Edwards R. Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI). In: European Society of Cardiology (ESC) Congress 2011. 2011, Paris, France: Oxford University Press.
Viswanathan G, Mayurathan G, Hildreth T, Worthley S, Zaman A. Health Related Quality of Life After Percutaneous Coronary Revascularisation in Patients with Previous Coronary Artery Bypass Grafts: A Two-Year Follow Up Study. Applied Research in Quality of Life 2011, 6(3), 311-324.
Kunadian V, Zaman A, Qiu WL. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. European Journal of Heart Failure 2011, 13(7), 773-784.
Viswanathan GN, Jardine J, Bhardwaj M, Adams P, Marshall S, Zaman A. Better clinical outcomes of participants in clinical research: Trial effect of an observational study in patients with non ST elevation acute coronary syndrome (NSTE-ACS). In: European Heart Journal: ESC Congress. 2010, Stockholm, Sweden: Oxford University Press.
Cubbon RM, Gale CP, Kearney LC, Brooksby P, Nolan J, Fox KA, Rajwani A, Baig W, Batin PD, Kahn MB, Zaman AG, Shah A, Lindsay S, Sapsford RJ, Wheatcroft SB, Witte KK, Kearney MT. Changing Characteristics and Outcomes of Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction: a Study Across Therapeutic Eras. In: American Heart Association Scientific Sessions. 2010, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
Viswanathan GN, Natarajan A, Marshall SM, Badimon JJ, Zaman AG. Higher Thrombus Burden and Impaired Clot Kinetics in Patients with Type 2 Diabetes Mellitus following Non ST-Elevation Acute Coronary Syndrome. In: American Heart Association Scientific Sessions. 2010, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
Viswanathan GN, Nelson AJ, Thompson L, Marshall SM, Zaman AG. Thrombus burden and response to clopidogrel in patients with type 2 diabets mellitus presenting with non ST elevation acute coronary syndrome. In: European Heart Journal: ESC Congress. 2010, Stockholm, Sweden: Oxford University Press.
Martin D, Zaman A, Hacker J, Mendelow D, Birchall D. Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics. British Journal of Radiology 2009, 82(special issue 1), s33-38.
Viswanathan G, Javed S, Mayurathan G, Sallehuddin S, Jamieson S, Zaman AG. Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact ?. Journal of Interventional Cardiology 2009, 22(2), 163-168.
Thomas HE, Avery PJ, Ahmed JM, Edwards R, Purcell I, Zaman AG, Arthur HM, Keavney BD. Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis. Heart 2009, 95(7), 555-558.
Campbell PG, Teo KSL, Worthley SG, Kearney MT, Tarique A, Natarajan A, Zaman AG. Non-invasive assessment of saphenous vein graft patency in asymptomatic patients. British Journal of Radiology 2009, 82(976), 291-295.
Kunadian V, Zaman A, Qiu W. Sodium Bicarbonate For The Prevention Of Contrast Induced Nephropathy: A Meta-Analysis. In: SCAI’s 32nd Annual Scientific Sessions. 2009, Las Vegas, Nevada, USA.
Lo TS, Zaman AG, Stables R, Fraser D, Oldryod KG, Hildick-Smith D, Nolan J. Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes. European Heart Journal 2008, 29(17), 2180-2180.
Hobson AR, McKenzie DB, Kunadian V, Purcell I, Zaman A, Dawkins KD, Curzen N. Malignancy: An unrecognized risk factor for coronary stent thrombosis?. Journal of Invasive Cardiology 2008, 20(4), E120-E123.
Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents. Diabetes and Vascular Disease Research 2008, 5(2), 138-144.
Natarajan A, Marshall SM, Worthley SG, Badimon JJ, Zaman AG. The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus. Journal of Thrombosis and Haemostasis 2008, 6(12), 2210-2213.
McClure SJ, Gall S, Schechter CB, Kearney M, Zaman AG. Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease. Journal of the American College of Cardiology 2007, 49(25), 2394-2397.
Birchall D, Zaman A, Hacker J, Davies G, Mendelow D. Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics. European Radiology 2006, 16(5), 1074-1083.
Zaman AG, Kearney MT, Schecter C, Worthley SG, Nolan J. Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. American Heart Journal 2004, 147(5), 823-827.
Kearney MT, Nolan J, Lee AJ, Brooksby PW, Prescott R, Shah AM, Zaman AG, Eckberg DL, Lindsay HS, Batin PD, Andrews R, Fox KAA. A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors. European Journal of Heart Failure 2003, 5(4), 489-497.
Zaman AG. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. New England Journal of Medicine 2003, 349(22), 2168-2168.
Kearney MT, Zaman AG, Eckberg DL, Lee AJ, Fox K, Prescott RJ, Wright DJ, Shah A, Nolan J. Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation. In: Circulation: American Heart Association Abstracts From Scientific Sessions. 2002, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, Eckberg DL, Zaman AG, Williams S, Neilson JMM, Nolan J. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. Journal of the American College of Cardiology 2002, 40(10), 1801-1808.
Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and Regression of Atherosclerotic Lesions Monitoring With Serial Noninvasive Magnetic Resonance Imaging. Circulation 2002, 105(8), 993-998.
Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhun R, Zaman A, Rodriguez OJ, Lev EI, Rauch U, Heflt G, Fallon JT, Crandall JP. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. Journal of the American College of Cardiology 2001, 38(5), 1307-1312.
Gall NP, Kearney MT, Zaman A, O'Nunain S, Fox KAA, Flapan A, Nolan J. Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study. Heart 2001, 86(2), 219-220.